{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:45:21Z","timestamp":1793094321170,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005921","name":"International Arctic Research Center, University of Alaska, Fairbanks","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008700","name":"Centre International de Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007698","name":"Sociedade Beneficente Israelita Brasileira Albert Einstein","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.canep.2023.102435","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:58:51Z","timestamp":1697417931000},"page":"102435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S1","title":["Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer"],"prefix":"10.1016","volume":"86","author":[{"given":"Rolando","family":"Herrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretto J.","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Constanza","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Patricia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Aranha","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"van De Wyngard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Canelo-Aybar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Balbin-Ramon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib1","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.canep.2023.102435_bib2","unstructured":"International Agency for Research on Cancer.WHO, European Code Against Cancer. https:\/\/cancer-code-europe.iarc.fr\/index.php\/en\/. (Accessed March 19 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib3","first-page":"1","article-title":"Toward the world code against cancer","volume":"4","author":"Espina","year":"2018","journal-title":"J. Glob. Oncol."},{"key":"10.1016\/j.canep.2023.102435_bib4","article-title":"Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework)","volume":"S1","author":"Espina","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2023.102435_bib5","article-title":"Latin America and the Caribbean Code Against Cancer 1st edition: Building capacity on cancer prevention to primary healthcare professionals","volume":"S1","author":"Feliu","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2023.102435_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12945","article-title":"Transmission routes and patterns of helicobacter pylori","author":"Duan","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.canep.2023.102435_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canep.2019.04.003","article-title":"Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: a systematic review and meta-analysis","volume":"60","author":"Curado","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2023.102435_bib8","article-title":"Reliability of diagnostic tests for helicobacter pylori infection","volume":"2011","author":"Redeen","year":"2011","journal-title":"Gastroenterol. Res Pr."},{"key":"10.1016\/j.canep.2023.102435_bib9","series-title":"WHO, Monographs on the evaluation of carcinigenic risks to humans: Schistosomes, liver flukes and Helicobacter pylori","author":"International Agency for Research on Cancer","year":"1994"},{"issue":"9","key":"10.1016\/j.canep.2023.102435_bib10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1433","article-title":"Oncogenic mechanisms of the Helicobacter pylori CagA protein","volume":"4","author":"Hatakeyama","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gtc.2013.01.003","article-title":"Gastric cancer: epidemiology and risk factors","volume":"42","author":"de Martel","year":"2013","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib12","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","article-title":"The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study","volume":"6","author":"Yang","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.canep.2023.102435_bib13","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research, Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. Continuous Update Project Expert Report 2018."},{"issue":"3","key":"10.1016\/j.canep.2023.102435_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4143\/crt.2019.151","article-title":"Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis","volume":"51","author":"Song","year":"2019","journal-title":"Cancer Res Treat."},{"issue":"3","key":"10.1016\/j.canep.2023.102435_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","article-title":"Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location","volume":"137","author":"Murphy","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canep.2023.102435_bib16","article-title":"Estimating the global burden of epstein-barr virus-associated gastric cancer: a systematic review and meta-analysis","author":"Hirabayashi","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2023.102435_bib17","unstructured":"International Agency for Research on Cancer.WHO.Global Cancer Observatory: Cancer Today. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/7-Stomach-fact-sheet.pdf. (Accessed March 15 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-326583","article-title":"Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis","author":"Ford","year":"2022","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib19","first-page":"414","article-title":"A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer","volume":"30","author":"Rokkas","year":"2017","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.canep.2023.102435_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.canep.2023.102435_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/den.14063","article-title":"Endoscopic screening for gastric cancer in Japan: Current status and future perspectives","volume":"34","author":"Mabe","year":"2022","journal-title":"Dig. Endosc."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.canep.2023.102435_bib23","unstructured":"International Agency for Research on Cancer. WHO. Global Cancer Observatory: Cancer Today, 2020. https:\/\/gco.iarc.fr\/. (Accesed March 15 2023)."},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0039-3399561","article-title":"Epidemiology of liver cancer in Latin America: current and future trends","volume":"40","author":"Carrilho","year":"2020","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.canep.2023.102435_bib25","first-page":"1","article-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Biological agents","volume":"100","year":"2012","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"issue":"9","key":"10.1016\/j.canep.2023.102435_bib26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2023.102435_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/875791","article-title":"HBV perinatal transmission","volume":"2013","author":"Umar","year":"2013","journal-title":"Int J. Hepatol."},{"issue":"33","key":"10.1016\/j.canep.2023.102435_bib28","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.3748\/wjg.v20.i33.11630","article-title":"Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis","volume":"20","author":"Tarocchi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"36","key":"10.1016\/j.canep.2023.102435_bib29","first-page":"868","article-title":"Centers for Disease Control and Prevention, Global progress toward universal childhood hepatitis B vaccination","volume":"52","year":"2003","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.canep.2023.102435_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bpg.2015.09.011","article-title":"Hepatitis B vaccination and prevention of hepatocellular carcinoma","volume":"29","author":"Kao","year":"2015","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12072-021-10156-z","article-title":"Neonatal hepatitis B vaccination protects mature adults from occult virus infection","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol. Int"},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050793","article-title":"The global impact of Hepatitis B vaccination on hepatocellular carcinoma","volume":"10","author":"Flores","year":"2022","journal-title":"Vaccin"},{"key":"10.1016\/j.canep.2023.102435_bib33","unstructured":"World Health Organization, Hepatitis B vaccines: WHO position paper - July 2017, 92(27) (2017) 369\u2013392."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European Association for the Study of the Liver. Electronic address, L. European Association for the Study of the, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.canep.2023.102435_bib36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"67","author":"Panel","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib37","first-page":"1170","article-title":"European Association for the Study of the Liver. Electronic address, C. Clinical Practice Guidelines Panel, E.G.B. representative, m. Panel, EASL recommendations on treatment of hepatitis C: Final update of the series(\u2606)","volume":"73","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canep.2023.102435_bib38","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib39","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.canep.2023.102435_bib40","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/S2214-109X(22)00545-9","article-title":"Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study","volume":"11","author":"Valls","year":"2023","journal-title":"Lancet Glob. Health"},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib41","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.canep.2023.102435_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2023.102435_bib43","unstructured":"World Health Organization, Human papillomavirus vaccines: WHO position paper(2022 update), 97(50) (2022) 645\u2013672."},{"issue":"10197","key":"10.1016\/j.canep.2023.102435_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2023.102435_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.canep.2023.102435_bib46","article-title":"Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening","volume":"S1","author":"Baena","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2023.102435_bib47","unstructured":"UNAIDS, UNAIDS DATA 2021. https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021_unaids_data. (Accessed March 20 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib48","unstructured":"Pan American Health Organization, HIV\/AIDS. https:\/\/www.paho.org\/es\/temas\/vihsida. (Accessed March 19 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib49","unstructured":"Pan American Health Organization, Plan of Action for the prevention and control of HIV and sexually transmitted infections 2016\u20132021., 2017. https:\/\/iris.paho.org\/handle\/10665.2\/34081."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/COH.0000000000000025","article-title":"Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk","volume":"9","author":"Borges","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.canep.2023.102435_bib51","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.canep.2015.08.014","article-title":"European Code against Cancer 4th Edition: process of reviewing the scientific evidence and revising the recommendations","volume":"39","author":"Minozzi","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.canep.2023.102435_bib52","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","article-title":"JAC,. Chapter 8: assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"issue":"31","key":"10.1016\/j.canep.2023.102435_bib53","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.3748\/wjg.v20.i31.10969","article-title":"Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus","volume":"20","author":"Rollan","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.canep.2023.102435_bib54","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib56","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.2014.10498","article-title":"Prevention of gastric cancer","volume":"312","author":"Herrero","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/hel.12050","article-title":"Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies","volume":"18","author":"Areia","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.canep.2023.102435_bib58","article-title":"Cost-effectiveness of prevention and early detection of gastric cancer in Western countries","volume":"50\u201351","author":"Lansdorp-Vogelaar","year":"2021","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.canep.2023.102435_bib59","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bpg.2013.09.005","article-title":"Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention","volume":"27","author":"Lansdorp-Vogelaar","year":"2013","journal-title":"Best. Pr. Res Clin. Gastroenterol."},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib60","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.31557\/APJCP.2018.19.12.3321","article-title":"Simulation models in gastric cancer screening: a systematic review","volume":"19","author":"Matsuda","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib61","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s12029-021-00726-7","article-title":"Cost-effectiveness of screening helicobacter pylori for gastric cancer prevention: a systematic review","volume":"53","author":"Sarmasti","year":"2022","journal-title":"J. Gastrointest. Cancer"},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1523-5378.1999.98057.x","article-title":"Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?","volume":"4","author":"Harris","year":"1999","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.23864","article-title":"Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results","volume":"124","author":"Yeh","year":"2009","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S0266462307080117","article-title":"Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese","volume":"24","author":"Xie","year":"2008","journal-title":"Int J. Technol. Assess. Health Care"},{"issue":"19","key":"10.1016\/j.canep.2023.102435_bib65","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3748\/wjg.14.3021","article-title":"Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model","volume":"14","author":"Xie","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacr.2009.01.022","article-title":"Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada","volume":"6","author":"Xie","year":"2009","journal-title":"J. Am. Coll. Radio."},{"issue":"Suppl 7","key":"10.1016\/j.canep.2023.102435_bib67","first-page":"13","article-title":"Cost-effectiveness of Helicobacter pylori screening and treatment for gastric cancer in Hong Kong: a decision analytic approach","volume":"20","author":"Wong","year":"2014","journal-title":"Hong. Kong Med. J."},{"key":"10.1016\/j.canep.2023.102435_bib68","article-title":"Sustaining communicable disease elimination efforts in the Americas in the wake of COVID-19","volume":"13","author":"Espinal","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.canep.2023.102435_bib69","unstructured":"World Health Organization, Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/246177. (Accessed March 20 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib70","unstructured":"World Health Organization, Guidelines for the screening,care and treatment of persons with chronic hepatitis C infection,Updated version, April 2016 https:\/\/apps.who.int\/iris\/handle\/10665\/205035. (Accessed March 24 2023 2023)."},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm. Rep."},{"issue":"6","key":"10.1016\/j.canep.2023.102435_bib72","first-page":"CD012143","article-title":"Direct-acting antivirals for chronic hepatitis C","volume":"6","author":"Jakobsen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib73","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib74","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/liv.13253","article-title":"Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients","volume":"36","author":"Su","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib75","first-page":"1","article-title":"Entecavir reduces hepatocarcinogenesis in chronic Hepatitis B patients","volume":"70","author":"Yasunaka","year":"2016","journal-title":"Acta Med Okayama"},{"issue":"9","key":"10.1016\/j.canep.2023.102435_bib76","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/apt.15499","article-title":"Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis","volume":"50","author":"Liu","year":"2019","journal-title":"Aliment Pharm. Ther."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiy391","article-title":"Reduced incidence of hepatocellular carcinoma in cirrhotic and noncirrhotic patients with chronic Hepatitis B treated with tenofovir-A propensity score-matched study","volume":"219","author":"Nguyen","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1470-2045(20)30729-4","article-title":"WHO launches strategy to accelerate elimination of cervical cancer","volume":"22","author":"Das","year":"2021","journal-title":"Lancet Oncol."},{"issue":"32 Pt A","key":"10.1016\/j.canep.2023.102435_bib79","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/j.vaccine.2017.12.078","article-title":"Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies","volume":"36","author":"Kreimer","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib80","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s13063-021-05608-8","article-title":"Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial","volume":"22","author":"Barnabas","year":"2021","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.canep.2023.102435_bib81","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males","volume":"2019","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-018-1098-3","article-title":"Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review","volume":"16","author":"Harder","year":"2018","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib84","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S2352-3018(19)30434-5","article-title":"Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis","volume":"7","author":"Kelly","year":"2020","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib85","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.canep.2023.102435_bib86","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.canep.2023.102435_bib87","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015123","article-title":"Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research","volume":"7","author":"Menon","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiph.2014.08.003","article-title":"Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV\/AIDS: a systematic review","volume":"8","author":"Cobucci","year":"2015","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.canep.2023.102435_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-5-8","article-title":"The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research","volume":"5","author":"Bratcher","year":"2010","journal-title":"Infect. Agent Cancer"},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/QAI.0000000000001798","article-title":"Impact of protease inhibitors on HIV-associated kaposi sarcoma incidence: a systematic review","volume":"79","author":"Chang","year":"2018","journal-title":"J. Acquir Immune Defic. Syndr."},{"issue":"5","key":"10.1016\/j.canep.2023.102435_bib91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/QAI.0b013e3181b327ca","article-title":"A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals","volume":"52","author":"Shiels","year":"2009","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.canep.2023.102435_bib92","unstructured":"Pan American Health Organization, Comprehensive Condom and Lubricant programming. https:\/\/www.paho.org\/en\/topics\/combination-hiv-prevention\/comprehensive-condom-and-lubricant-programming. (Accessed March 13 2023)."},{"key":"10.1016\/j.canep.2023.102435_bib93","doi-asserted-by":"crossref","DOI":"10.1177\/1745506518816599","article-title":"Systematic literature review of risk factors for cervical cancer in the Chinese population","volume":"vol. 14","author":"Li","year":"2018","journal-title":"Women'S. Health"},{"issue":"11","key":"10.1016\/j.canep.2023.102435_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.canep.2023.102435_bib95","series-title":"Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination","year":"2023"},{"issue":"13","key":"10.1016\/j.canep.2023.102435_bib96","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.canep.2023.102435_bib97","unstructured":"Strategic Advisory Group of Experts (SAGE) on Inmunization, Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: conclusions and recommendations, WHO:Geneva,2022."},{"key":"10.1016\/j.canep.2023.102435_bib98","unstructured":"World Health Organization, Global strategy to accelerate the elimination of cervical cancer as a public health problem., 2020. apps.who.int\/iris\/handle\/10665\/336583."},{"key":"10.1016\/j.canep.2023.102435_bib99","unstructured":"UNAIDS\/WHO, Position Statement on Condoms and HIV prevention. https:\/\/data.unaids.org\/una-docs\/condom-policy_jul04_en.pdf. (Accessed (Accesed March 20 2023."},{"issue":"10194","key":"10.1016\/j.canep.2023.102435_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(19)31146-8","article-title":"Oral diseases: a global public health challenge","volume":"394","author":"Peres","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2023.102435_bib101","unstructured":"World Health Organization, Oral health, 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/oral-health. (Accessed March 24 2023)."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0022034520952401","article-title":"Periodontitis, edentulism, and risk of mortality: a systematic review with meta-analyses","volume":"100","author":"Romandini","year":"2021","journal-title":"J. Dent. Res"},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s40496-019-0213-7","article-title":"Oral health and cancer","volume":"6","author":"Chung","year":"2019","journal-title":"Curr. Oral. Health Rep."},{"issue":"4","key":"10.1016\/j.canep.2023.102435_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/cco.2019.07.12","article-title":"Gallbladder cancer in South America: epidemiology and prevention","volume":"8","author":"Salazar","year":"2019","journal-title":"Chin. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canep.2023.102435_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020234","article-title":"Environmental and lifestyle risk factors in the carcinogenesis of gallbladder cancer","volume":"12","author":"Perez-Moreno","year":"2022","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.canep.2023.102435_bib106","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;, IARC: Lyon, France,2002; Volume 82, ISBN: 978\u201392-832\u20131582-0."},{"issue":"1","key":"10.1016\/j.canep.2023.102435_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2017.95","article-title":"Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms","volume":"98","author":"Chen","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.canep.2023.102435_bib108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2018.04.019","article-title":"Cholecystectomy and risk of metabolic syndrome","volume":"53","author":"Di Ciaula","year":"2018","journal-title":"Eur. J. Intern Med"},{"issue":"12","key":"10.1016\/j.canep.2023.102435_bib109","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","volume":"142","author":"Maucort-Boulch","year":"2018","journal-title":"Int J. Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782123001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:31:11Z","timestamp":1761802271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782123001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":109,"alternative-id":["S1877782123001157"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2023.102435","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2023.102435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102435"}}